Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Ophthalmic Surgical Devices Market by Product (Ophthalmic Surgical Systems, Intraocular Implants (IOLs), Minimally Invasive or Micro-Invasive Glaucoma Surgery (MIGS) Devices, Ophthalmic Surgical Instruments) and Forecast 2024-2031


Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Cataract and glaucoma are the leading causes of blindness worldwide. Cataract accounts for approximately 16 million cases of blindness worldwide. In most countries of Africa and Asia, it accounts for approximately half of all blindness. Glaucoma is the second most common cause of blindness. Glaucoma can be treated with medication and alleviated by a small operation but is not curable.

An increased intraocular pressure (IOP) is known as major risk factor. Over the last decade several ophthalmic surgical products including novel minimally invasive surgical treatment options and devices for glaucoma have been developed. All these developments aim to cause as little trauma as possible to the eye, to safely, effectively, and sustainably reduce intraocular pressure, to produce reproducible results, and to be easy to adopt.

A wide range of ophthalmic surgery systems and micro instruments have applications in ophthalmic surgery in various hospitals and clinics. An intraocular lens (IOL) is a clear, artificial lens implant used to replace a cloudy natural lens in cataract surgery. IOLs also are used for a type of vision correction surgery called refractive lens exchange.

Currently, drainage devices that are implanted by means of micro-invasive glaucoma surgery (MIGS) present a promising approach for IOP lowering. (MIGS is gaining more and more interest and popularity. The possible reduction of the number of glaucoma medications, the ab interno approach without damaging the conjunctival tissue, and the probably safer procedures compared to incisional surgical methods.

The global ophthalmic surgical devices market research report provides market size (Revenue USD Million 2021 to 2031), market share analysis, growth trends and forecast (CAGR%, 2024 to 2031).

The global ophthalmic surgical devices market segmentation is based on product (ophthalmic surgical systems, intraocular implants (IOLs), minimally invasive or micro-invasive glaucoma surgery (MIGs) devices, ophthalmic surgical instruments).

The global ophthalmic surgical products market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

In addition, the global ophthalmic surgical products market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries.

The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global ophthalmic surgical devices market and profiled in this report include Alcon (Novartis/Ivantis, Inc.), Bausch + Lomb, Inc. (Valeant Pharmaceuticals International), Carl Zeiss Meditec AG, Lumibird Medical (Ellex Medical Lasers Ltd./Quantel Medical), Glaukos Corporation, IRIDEX Corporation, Johnson & Johnson Vision (J & J), and Lumenis Be Ltd. (Boston Scientific Corporation).

Other notable players in the global market include ARC Laser GmbH, Avedro, Inc., ClarVista Medical, Eye Tech Care, HOYA Surgical Optics, HumanOptics AG, Santen Pharmaceuticals Co. Ltd. (InnFocus), iSTAR Medical, LensGen, Inc., LENSAR, Inc., Lenstec, LIGHTMED, NIDEK Co. Ltd., Opthec, PhysIOL, Rayner, RxSight, PowerVision, STAAR Surgical, and Topcon Medical Systems.

DATA INCLUDED: Ophthalmic Surgical Devices Market Size, Ophthalmic Surgical Devices Market Share, Ophthalmic Surgical Devices Market Growth Rates, Ophthalmic Surgical Devices Market Trends, and Ophthalmic Surgical Devices Market Forecast to 2031

Market Data:

  • Base year for estimation: 2023
  • Actual estimates/Historical data: 2021-2031
  • Forecast period: 2024-2031
  • Market representation: Revenue in $million and CAGR % from 2024 to 2031
  • Regional scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
  • Country scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE and others.
  • Report coverage: Revenue forecast, company share, competitive landscape, growth factors, and trends
  • 15% free customization scope: Any specific or custom requirements, which is not currently within the scope of the report, will be provided as a part of customization.

Qualitative Analysis:

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Key market opportunities
  • Market size
  • Growth trends
  • Porter’s five forces analysis
  • Market attractiveness analysis
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product portfolio
    • Strategic insights
    • Recent developments

Quantitative Analysis:

  • Market size estimates and forecast for all segments
  • Regional market size estimated and forecast for major countries
  • Company financial performance
  • Competitive landscape: Company market share analysis

Please contact us for offers on individual or multiple report purchases.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation ($million, 2021-2031)
    • Forecast Estimation ($million and CAGR%, 2024-2031)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Equipment
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
      • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Equipment or Brand Type
    • Modality Type
    • Indication Type
    • Procedure Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What are the product or procedure volumes by country and regions?

Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)

Ophthalmic Surgical Products Market

1. Product
1.1. Ophthalmic Surgical Systems
1.2. Intraocular Implants (IOLs)
1.3. Minimally Invasive or Micro-Invasive Glaucoma Surgery (MIGS) Devices
1.4. Ophthalmic Surgical Instruments

2. Geography
2.1. North America (U.S., Canada)
2.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.3. Asia Pacific (Japan, China, India, Rest of APAC
2.4. Latin America (Brazil, Mexico, Rest of LA)
2.5. Rest of the World

3. Company Profiles
3.1. Alcon (Novartis)
3.2. Bausch + Lomb, Inc. (Bausch + Lomb/Valeant Pharmaceuticals)
3.3. Carl Zeiss Meditec AG
3.4. Lumibird Medical (Ellex Medical Lasers Ltd./Quantel Medical)
3.5. Glaukos Corporation
3.6. IRIDEX Corporation
3.7. Johnson & Johnson Vision (J & J)
3.8. Lumenis Be Ltd. (Boston Scientific Corporation)

    Request ToC / Sample Report

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com